))
Biopharma Perspective on Early Venture Investing and R&D
Manage episode 154229730 series 1116730
Indhold leveret af Columbia Tech Ventures and Columbia Technology Ventures. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Columbia Tech Ventures and Columbia Technology Ventures eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Presenting a panel discussion with Marian Nakada (Johnson & Johnson Innovation – JJDC), Bob Silverman (Roche) and Steven Weinstein (Novartis Ventures), moderated by CTV’s executive director Orin Herskowitz. The conversation touches on the various ways Big Pharma & Biotech are using venture capital investing, regional innovation centers, joint ventures, university research sponsorship, and IP licensing to source their next blockbuster products (as well as generate equity returns). The panelists share their perspectives on venture capital investing strategies in biopharma, how to pitch strategic investors, the surge in biotech IPOs, hot research areas within biopharma, and best practices for establishing R&D partnerships between industry and academia.
…
continue reading
15 episoder
Del
